An experimental urine test that could be used detect kidney cancer in its early stages has shown promise in a recent study. The test is being developed for commercial use by Epigenomics in Seattle, Washington, and their collaborators.
An experimental urine test that could be used detect kidney cancer in its early stages has shown promise in a recent study. The test is being developed for commercial use by Epigenomics in Seattle, Washington, and their collaborators.
